Introduction:

The care of dependency-related skin injuries, lower limb ulcers and other types of superficial wounds, represents a major challenge for healthcare professionals. These types of injuries, when superficial, require a specific approach because of the high risk of developing into deeper wounds, which can affect the health and quality of life of sufferers, and may require more complex and costly treatments. Hyperoxygenated fatty acids (HOFA) are nowadays considered as one of the most important measures for the prevention of these types of injuries. The Mepentol® range of products (Mepentol®, Mepentol® Leche and Mepentol AGHO) are the only HOFA CE certifies medical devices IIb and can therefore also be used in the treatment of superficial lesions. The coexistence of integrated, but damaged skin, and superficial lesions is a very common situation in clinical practice.

Patients, material and methods:

The results of a clinical case series in which Mepentol® and Mepentol® Leche have been used for the treatment of superficial chronic wounds are presented. Patients with superficial chronic wounds of different etiology who were not allergic to any of the components of these products and who consented to participate in the evaluation were included. Lesions were included in the evaluation until healing or resolution was achieved.

Results:

The case series comprised 54 patients with 73 superficial chronic lesions: 45 lower extremity ulcers, 10 skin lesions related to dependence, 5 skin lesions related to venous insufficiency and 13 lesions of other types. The median age of the lesions was 39 days. 45 lesions (61.6%) were treated with Mepentol® and 28 (38.4%) with Mepentol® Leche. The 73 lesions included in the study healed in a median of 23 days. There were no complications or episodes of local infection.

Discussion:

The use of Mepentol® and Mepentol® Leche has been shown to be effective in the healing of superficial chronic wounds of different etiologies. The use of both products in skin care in patients at risk, which is often associated with superficial lesions, is an excellent option to improve prevention outcomes and to treat these superficial lesions early and effectively.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )